Corrigendum to: Histidine-rich glycoprotein gene polymorphism in patients with recurrent miscarriage (Acta Obstetricia et Gynecologica Scandinavica, (2013), 92, 8, (974-977), 10.1111/aogs.12155);Histidine-rich glycoprotein gene polymorphism in patients with recurrent miscarriage

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 8, 2013, Pages 974-977

  Lindgren, Karin E ^a   Kårehed, Karin ^a   Karypidis, Helena ^a   Hosseini, Frida ^b   Bremme, Katarina ^c   Landgren, Britt Marie ^d   Skjöldebrand Sparre, Lottie ^b   Stavreus Evers, Anneli ^a   Sundström Poromaa, Inger ^a   Åkerud, Helena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genotype; histidine rich glycoprotein; infertility; recurrent miscarriage; single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; GLYCOPROTEIN; HISTIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION;

EID: 84880276093     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.13049     Document Type: Erratum

References (12)

1. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N,. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006; 21 (9): 2216-22.
2. Rai R, Regan L,. Recurrent miscarriage. Lancet 2006; 368 (9535): 601-11.
3. Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR,. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol. 2012; 67 (4): 341-7.
4. Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD,. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood 2011; 117 (7): 2093-101.
5. Nordqvist S, Karehed K, Hambiliki F, Wanggren K, Stavreus-Evers A, Akerud H,. The presence of histidine-rich glycoprotein in the female reproductive tract and in embryos. Reprod Sci. 2010; 17 (10): 941-7.
6. Karehed K, Wikstrom AK, Olsson AK, Larsson A, Olovsson M, Akerud H,. Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia. Acta Obstet Gynecol Scand. 2010; 89 (1): 131-9.
7. Nordqvist S, Karehed K, Stavreus-Evers A, Akerud H,. Histidine-rich glycoprotein polymorphism and pregnancy outcome: a pilot study. Reprod Biomed Online. 2011; 23 (2): 213-9.
8. Reynolds LP, Borowicz PP, Caton JS, Vonnahme KA, Luther JS, Buchanan DS, et al. Uteroplacental vascular development and placental function: an update. Int J Dev Biol. 2010; 54 (2-3): 355-66.
9. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH,. Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev. 2003; 66 (1): 24-31.
10. Lash GE, Innes BA, Drury JA, Robson SC, Quenby S, Bulmer JN,. Localization of angiogenic growth factors and their receptors in the human endometrium throughout the menstrual cycle and in recurrent miscarriage. Hum Reprod. 2012; 27 (1): 183-95.
11. Febbraio M, Hajjar DP, Silverstein RL,. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 2001; 108 (6): 785-91.
12. Edwards A, van den Heuvel M, Wessels J, LaMarre J, Croy BA, Tayade C,. Expression of angiogenic basic fibroblast growth factor, platelet derived growth factor, thrombospondin-1 and their receptors at the porcine maternal-fetal interface. Reprod Biol Endocrinol. 2011. doi: 10.1186/1477-7827-9-5.